Form D · Other Health Care
VASCUGENIX INC.
Little Rock, AR · CIK 0001786847
Offering snapshot reported May 26, 2021 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $150K Reported outside-investor minimum
- First sale
- May 25, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2021 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Sep 8, 2020 | Amendment | $425,000 | $405,000vs Sep 16, 2019 | 10 | SEC filing |
| Sep 16, 2019 | Initial | $20,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-400721
Simple Agreement for Future Equity
Source: Form D, filed May 26, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Noah Asher | Director, Executive |
| Stephen R Bova | Director |
| Dwight Chrisman | Director, Executive |
| Martial Trigeaud | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
22501 Denny Road
Little Rock, AR, 72223
Little Rock, AR, 72223